Letrozole Initiation Timing and Protocol in PCOS Patients with Irregular Cycles

Timing of Initiation

In women with PCOS who experience any spontaneous menstrual bleeding, letrozole should be started on cycle day 3 or day 5 of that bleeding. [1][2]
When spontaneous bleeding is absent (amenorrhea), a short course of progesterone should be given to induce withdrawal bleeding before initiating letrozole. [1][2]
After progesterone‑induced withdrawal bleeding, letrozole is begun on day 3 or day 5 of the induced cycle, providing a predictable start point for ovulation induction. 2

The standard first‑line regimen is letrozole 2.5–5 mg taken daily for five consecutive days, beginning on day 3–5 of either spontaneous or progesterone‑induced bleeding. [1][2]

Ovulation should be confirmed each cycle by transvaginal ultrasound monitoring of follicular development or by using ovulation predictor kits. 1
Progesterone induction for amenorrheic patients typically uses medroxyprogesterone acetate 10 mg daily for 5–10 days to create the withdrawal bleed that defines cycle day 1. 2

Letrozole is now recommended as the first‑line oral agent for anovulatory infertility in PCOS, superseding clomiphene citrate because it yields higher live‑birth rates while maintaining a comparable safety profile. [1][2]
Initiating letrozole on a defined day (3 or 5) after either spontaneous or induced bleeding creates a systematic treatment timeline, avoiding delays associated with waiting for unpredictable spontaneous cycles. 2